Stonepine Capital Management, LLC Evolus, Inc. Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 1,264,651 shares of EOLS stock, worth $17.7 Million. This represents 11.27% of its overall portfolio holdings.
Number of Shares
1,264,651
Previous 1,369,821
7.68%
Holding current value
$17.7 Million
Previous $22.2 Billion
37.08%
% of portfolio
11.27%
Previous 14.02%
Shares
19 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$72 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$69.9 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$56.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$44.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$43.8 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $785M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...